{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:40:32Z","timestamp":1793252432982,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.clinre.2015.12.012","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T10:23:01Z","timestamp":1454408581000},"page":"517-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains"],"prefix":"10.1016","volume":"40","author":[{"given":"Nelly","family":"Muller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Le Thuaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bastuji-Garin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Deforges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Delchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2015.12.012_bib0140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMc1006158","article-title":"Helicobacter pylori infection","volume":"363","author":"Graham","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2015.12.012_bib0275","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinre.2015.12.012_bib0150","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.gcb.2009.07.004","article-title":"Gastroduodenal ulcer before and after Helicobacter pylori","volume":"33","author":"Bommelaer","year":"2009","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.clinre.2015.12.012_bib0155","first-page":"646","article-title":"Management of Helicobacter pylori infection--the Maastricht IV","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Florence Consensus Report Gut"},{"key":"10.1016\/j.clinre.2015.12.012_bib0160","first-page":"409","article-title":"Worldwide H.\u00a0pylori antibiotic resistance: a systematic","volume":"19","author":"De Francesco","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.clinre.2015.12.012_bib0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","article-title":"Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial","volume":"381","author":"Liou","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2015.12.012_bib0170","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14656566.2013.782286","article-title":"A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)","volume":"14","author":"Marin","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinre.2015.12.012_bib0175","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1128\/JCM.00744-09","article-title":"Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori","volume":"47","author":"Cambau","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinre.2015.12.012_bib0180","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","article-title":"Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial","volume":"377","author":"Malfertheiner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2015.12.012_bib0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/apt.12808","article-title":"Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori","volume":"40","author":"Delchier","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2015.12.012_bib0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2006.11.007","article-title":"Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility","volume":"29","author":"Cattoir","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinre.2015.12.012_bib0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2015.12.012_bib0200","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jac\/dkt061","article-title":"High secondary resistance to quinolones in German Helicobacter pylori clinical isolates","volume":"68","author":"Wueppenhorst","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinre.2015.12.012_bib0205","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1572-0241.2003.t01-1-07288.x","volume":"98","author":"Laine","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2015.12.012_bib0210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2036.2003.01434.x","article-title":"Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study","volume":"17","author":"O\u2019Morain","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2015.12.012_bib0215","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1572-0241.2002.05600.x","article-title":"Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection","volume":"97","author":"Dore","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2015.12.012_bib0220","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-5378.2003.00150.x","article-title":"Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen","volume":"8","author":"Dore","year":"2003","journal-title":"Helicobacter"},{"key":"10.1016\/j.clinre.2015.12.012_bib0225","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10620-013-2900-x","article-title":"Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H.\u00a0pylori infection","volume":"59","author":"Gisbert","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2015.12.012_bib0230","article-title":"Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study","volume":"11","author":"Liang","year":"2013","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.clinre.2015.12.012_bib0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jcp.41.2.207","article-title":"Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies","volume":"41","author":"Goodwin","year":"1988","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clinre.2015.12.012_bib0240","first-page":"CD008337","article-title":"Optimum duration of regimens for Helicobacter pylori eradication","volume":"12","author":"Yuan","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.clinre.2015.12.012_bib0245","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1365-2036.2003.01764.x","article-title":"Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance","volume":"18","author":"Miehlke","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2015.12.012_bib0250","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2036.2000.00770.x","article-title":"Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study","volume":"14","author":"Graham","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2015.12.012_bib0255","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.gtc.2015.05.003","article-title":"How to effectively use bismuth quadruple therapy: the good, the bad, and the ugly","volume":"44","author":"Graham","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.clinre.2015.12.012_bib0260","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1523-5378.2003.00158.x","article-title":"A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarythromycin","volume":"8","author":"Miehlke","year":"2003","journal-title":"Helicobacter"},{"key":"10.1016\/j.clinre.2015.12.012_bib0265","first-page":"177","article-title":"Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence","volume":"12","author":"Graham","year":"2014","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.clinre.2015.12.012_bib0270","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1136\/gutjnl-2015-309900","article-title":"Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy","volume":"64","author":"Zhang","year":"2015","journal-title":"Gut"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740116000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740116000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:23:55Z","timestamp":1761895435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740116000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2210740116000036"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2015.12.012","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2015.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}